An update on peptide-based therapies for type 2 diabetes and obesity
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An update on peptide-based therapies for type 2 diabetes and obesity
Authors
Keywords
-
Journal
PEPTIDES
Volume 161, Issue -, Pages 170939
Publisher
Elsevier BV
Online
2023-01-04
DOI
10.1016/j.peptides.2023.170939
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- National Institute for Health and Care Excellence (NICE) guidance on heart valve disease
- (2023) Benoy Nalin Shah HEART
- Impact of Cotadutide drug on patients with type 2 diabetes mellitus: a systematic review and meta-analysis
- (2022) Mahmoud M. Ali et al. BMC Endocrine Disorders
- Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis
- (2022) John J. Nestor et al. Scientific Reports
- Tirzepatide for the treatment of adults with type 2 diabetes: an endocrine perspective
- (2022) Christophe De Block et al. DIABETES OBESITY & METABOLISM
- Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes
- (2022) Nicolai J. Wewer Albrechtsen et al. DIABETES OBESITY & METABOLISM
- WITHDRAWN: American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update
- (2022) Lawrence Blonde et al. Endocrine Practice
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes
- (2022) Hongwei Jiang et al. Nature Communications
- LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
- (2022) Tamer Coskun et al. Cell Metabolism
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2022) Melanie J. Davies et al. DIABETOLOGIA
- Potential of a glucagon‐like peptide‐1 receptor /glucose‐dependent insulinotropic polypeptide receptor/ glucagon receptor triagonist for the treatment of obesity and type 2 diabetes
- (2022) Eiichi Araki et al. Journal of Diabetes Investigation
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists
- (2022) Elena Jiménez-Martí et al. Nutrients
- Why are GLP-1 receptor agonists in short supply?
- (2022) Clifford J. Bailey British Journal of Diabetes
- New perspectives in oral peptide delivery
- (2021) Alessandra T. Zizzari et al. DRUG DISCOVERY TODAY
- Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
- (2021) Alessandro Mantovani et al. Metabolites
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
- (2021) Lone B Enebo et al. LANCET
- Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
- (2021) Rajaa Nahra et al. DIABETES CARE
- Development of Cagrilintide, a Long-Acting Amylin Analogue
- (2021) Thomas Kruse et al. JOURNAL OF MEDICINAL CHEMISTRY
- Kilogram-Scale GMP Manufacture of Tirzepatide Using a Hybrid SPPS/LPPS Approach with Continuous Manufacturing
- (2021) Michael O. Frederick et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist
- (2021) Martin Bossart et al. Cell Metabolism
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
- (2021) David C W Lau et al. LANCET
- The incretin/glucagon system as a target for pharmacotherapy of obesity
- (2021) Stefano Del Prato et al. Obesity Reviews
- GIP as a therapeutic target in diabetes and obesity: insight from incretin co-agonists
- (2020) Jens Juul Holst et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A look to the future in non‐alcoholic fatty liver disease: Are glucagon‐like peptide‐1 analogues or sodium‐glucose co‐transporter‐2 inhibitors the answer?
- (2020) Rebecca K. Vincent et al. DIABETES OBESITY & METABOLISM
- GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
- (2020) Michael A. Nauck et al. Molecular Metabolism
- The liver–alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels
- (2020) Christina Gar et al. DIABETOLOGIA
- The Discovery and Development of Liraglutide and Semaglutide
- (2019) Lotte Bjerre Knudsen et al. Frontiers in Endocrinology
- Efficacy, safety, and mechanistic insights of cotadutide a dual receptor glucagon-like peptide-1 and glucagon agonist
- (2019) Victoria E R Parker et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
- (2018) Tamer Coskun et al. Molecular Metabolism
- Unimolecular Polypharmacy for Treatment of Diabetes and Obesity
- (2016) Matthias H. Tschöp et al. Cell Metabolism
- Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus
- (2016) Kristy Iglay et al. CURRENT MEDICAL RESEARCH AND OPINION
- Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes
- (2015) M. C. Riddle et al. DIABETES OBESITY & METABOLISM
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
- (2015) Jesper Lau et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search